EDN1 and pulmonary fibrosis: Endothelin-1 has also been suggested as a biomarker in patients with interstitial lung disease, independent of the condition’s form (idiopathic pulmonary fibrosis, where ET-1 plays a profibrotic role, or interstitial lung disease associated with autoimmune diseases) [40].